H. Allain
Impact in
- Psychiatry and Mental health top 2%
- Epilepsy research and treatment
- Neurology top 2%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
Papers in
- Pharmacology 35
- Cholinesterase and Neurodegenerative Diseases 20
- Co-authors
- Danièle Bentué‐Ferrer (80 shared papers)Jean‐Michel Reymann (31 shared papers)J.M. Gandon (19 shared papers)Stéphane Schück (20 shared papers)Alain Lieury (17 shared papers)Olivier Tribut (9 shared papers)F. Le Coz (14 shared papers)Élisabeth Polard (12 shared papers)
- Journals
- Human Psychopharmacology Clinical and Experimental (11 papers)European Psychiatry (8 papers)Dementia and Geriatric Cognitive Disorders (7 papers)Psychopharmacology (5 papers)Clinical Neuropharmacology (4 papers)
- Partner nations
- FranceSwitzerlandGermany
In The Last Decade
H. Allain
195 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 151
- Psychiatry and Mental health 528
- Neurology 446
- Cellular and Molecular Neuroscience 510
- Biological Psychiatry 53
- Pharmacology 360
Countries citing papers authored by H. Allain
This map shows the geographic impact of H. Allain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Allain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Allain more than expected).
Fields of papers citing papers by H. Allain
This network shows the impact of papers produced by H. Allain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Allain. The network helps show where H. Allain may publish in the future.
Co-authors
The 25 scholars most cited alongside H. Allain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 206 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 118 | |
| 2 | 2006 | 106 | |
| 3 | 1998 | 77 | |
| 4 | Effect of two doses of ginkgo biloba extract (EGb 761) on the dual-coding test in elderly subjects. | 1993 | 74 |
| 5 | 1993 | 65 | |
| 6 | 2002 | 63 | |
| 7 | 1992 | 60 | |
| 8 | 2000 | 58 | |
| 9 | 1991 | 51 | |
| 10 | 2013 | 49 | |
| 11 | 2002 | 47 | |
| 12 | 2003 | 45 | |
| 13 | 2004 | 43 | |
| 14 | 2002 | 43 | |
| 15 | 2007 | 43 | |
| 16 | 1999 | 40 | |
| 17 | 1991 | 40 | |
| 18 | 1983 | 36 | |
| 19 | 1995 | 35 | |
| 20 | 1999 | 34 |
About H. Allain
H. Allain is a scholar working on Pharmacology, Psychiatry and Mental health, Cognitive Neuroscience, Neurology and Cellular and Molecular Neuroscience, having authored 206 papers that have together received 2.7k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (24 papers), Neuroscience and Neuropharmacology Research (22 papers), Cholinesterase and Neurodegenerative Diseases (20 papers), Neurological Disorders and Treatments (11 papers), Sleep and Wakefulness Research (10 papers), Neurological disorders and treatments (10 papers), Alzheimer's disease research and treatments (10 papers) and Memory and Neural Mechanisms (10 papers). The work is most often cited by research in Psychiatry and Mental health (528 citations), Neurology (446 citations), Cellular and Molecular Neuroscience (510 citations), Biological Psychiatry (53 citations) and Pharmacology (360 citations). H. Allain has collaborated with scholars based in France, Switzerland and Germany. Frequent co-authors include Danièle Bentué‐Ferrer, Jean‐Michel Reymann, J.M. Gandon, Stéphane Schück, Alain Lieury, Olivier Tribut, F. Le Coz, Élisabeth Polard, Alain Patat and Gilles Edan. Their work appears in journals such as Human Psychopharmacology Clinical and Experimental, European Psychiatry, Dementia and Geriatric Cognitive Disorders, Psychopharmacology and Clinical Neuropharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.